Observations following discontinuation of long-term denosumab therapy
McClung, M. R., Wagman, R. B., Miller, P. D., Wang, A., Lewiecki, E. M.
Published in Osteoporosis international (01.05.2017)
Published in Osteoporosis international (01.05.2017)
Get full text
Journal Article
Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial
Bone, H. G., Dempster, D. W., Eisman, J. A., Greenspan, S. L., McClung, M. R., Nakamura, T., Papapoulos, S., Shih, W. J., Rybak-Feiglin, A., Santora, A. C., Verbruggen, N., Leung, A. T., Lombardi, A.
Published in Osteoporosis international (01.02.2015)
Published in Osteoporosis international (01.02.2015)
Get full text
Journal Article
Fracture risk remains reduced one year after discontinuation of risedronate
Watts, N. B., Chines, A., Olszynski, W. P., McKeever, C. D., McClung, M. R., Zhou, X., Grauer, A.
Published in Osteoporosis international (01.03.2008)
Published in Osteoporosis international (01.03.2008)
Get full text
Journal Article
Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial
McClung, M. R., Lewiecki, E. M., Geller, M. L., Bolognese, M. A., Peacock, M., Weinstein, R. L., Ding, B., Rockabrand, E., Wagman, R. B., Miller, P. D.
Published in Osteoporosis international (01.01.2013)
Published in Osteoporosis international (01.01.2013)
Get full text
Journal Article
The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis
Brown, J P, Kendler, D L, McClung, M R, Emkey, R D, Adachi, J D, Bolognese, M A, Li, Z, Balske, A, Lindsay, R
Published in Calcified tissue international (01.08.2002)
Published in Calcified tissue international (01.08.2002)
Get full text
Journal Article
Effects of risedronate on fracture risk in postmenopausal women with osteopenia
Siris, E. S., Simon, J. A., Barton, I. P., McClung, M. R., Grauer, A.
Published in Osteoporosis international (01.05.2008)
Published in Osteoporosis international (01.05.2008)
Get full text
Journal Article
Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year data
McClung, M. R., Zanchetta, J. R., Racewicz, A., Roux, C., Benhamou, C.-L., Man, Z., Eusebio, R. A., Beary, J. F., Burgio, D. E., Matzkin, E., Boonen, S., Delmas, P.
Published in Osteoporosis international (01.01.2013)
Published in Osteoporosis international (01.01.2013)
Get full text
Journal Article
Monthly dosing of 75 mg risedronate on 2 consecutive days a month: efficacy and safety results
Delmas, P. D., Benhamou, C. L., Man, Z., Tlustochowicz, W., Matzkin, E., Eusebio, R., Zanchetta, J., Olszynski, W. P., Recker, R. R., McClung, M. R.
Published in Osteoporosis international (01.07.2008)
Published in Osteoporosis international (01.07.2008)
Get full text
Journal Article
Bone safety with risedronate: histomorphometric studies at different dose levels and exposure
Recker, R. R., Ste-Marie, L.-G., Chavassieux, P., McClung, M. R., Lundy, M. W.
Published in Osteoporosis international (01.01.2015)
Published in Osteoporosis international (01.01.2015)
Get full text
Journal Article
Osteoanabolic therapy for osteoporosis in women
McClung, M. R., Clark, A. L.
Published in Climacteric : the journal of the International Menopause Society (01.02.2022)
Published in Climacteric : the journal of the International Menopause Society (01.02.2022)
Get full text
Journal Article
Monthly Oral Ibandronate Therapy in Postmenopausal Osteoporosis: 1‐Year Results From the MOBILE Study
Miller, Paul D, Mcclung, Michael R, Macovei, Liviu, Stakkestad, Jacob A, Luckey, Marjorie, Bonvoisin, Bernard, Reginster, Jean‐Yves, Recker, Robert R, Hughes, Claire, Lewiecki, E Michael, Felsenberg, Dieter, Delmas, Pierre D, Kendler, David L, Bolognese, Michael A, Mairon, Nicole, Cooper, Cyrus
Published in Journal of bone and mineral research (01.08.2005)
Published in Journal of bone and mineral research (01.08.2005)
Get full text
Journal Article
Web Resource
Effect of Risedronate on the Risk of Hip Fracture in Elderly Women
McClung, Michael R, Geusens, Piet, Miller, Paul D, Zippel, Hartmut, Bensen, William G, Roux, Christian, Adami, Silvano, Fogelman, Ignac, Diamond, Terrence, Eastell, Richard, Meunier, Pierre J, Wasnich, Richard D, Greenwald, Maria, Kaufman, Jean-Marc, Chesnut, Charles H, Reginster, Jean-Yves
Published in The New England journal of medicine (01.02.2001)
Published in The New England journal of medicine (01.02.2001)
Get full text
Journal Article
Vertebral Fractures: Clinical Importance and Management
Kendler, D.L., MD, Bauer, D.C., MD, Davison, K.S., PhD, Dian, L., MBBS, Hanley, D.A., MD, Harris, S.T., MD, McClung, M.R., MD, Miller, P.D., MD, Schousboe, J.T., MD, Yuen, C.K., MD, MBA, Lewiecki, E.M., MD
Published in The American journal of medicine (01.02.2016)
Published in The American journal of medicine (01.02.2016)
Get full text
Journal Article
New management options for osteoporosis with emphasis on SERMs
McClung, M. R.
Published in Climacteric : the journal of the International Menopause Society (18.12.2015)
Published in Climacteric : the journal of the International Menopause Society (18.12.2015)
Get full text
Journal Article
A single dose of zoledronate preserves bone mineral density for up to 2 years after a second course of romosozumab
McClung, M. R., Bolognese, M. A., Brown, J. P., Reginster, J.-Y., Langdahl, B. L., Maddox, J., Shi, Y., Rojeski, M., Meisner, P. D., Grauer, A.
Published in Osteoporosis international (01.11.2020)
Published in Osteoporosis international (01.11.2020)
Get full text
Journal Article
Web Resource
Effect of denosumab on trabecular bone score in postmenopausal women with osteoporosis
McClung, M. R., Lippuner, K., Brandi, M. L., Zanchetta, J. R., Bone, H. G., Chapurlat, R., Hans, D., Wang, A., Zapalowski, C., Libanati, C.
Published in Osteoporosis international (01.10.2017)
Published in Osteoporosis international (01.10.2017)
Get full text
Journal Article